Back to Search Start Over

DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine.

Authors :
Bailly C
Laine W
Baldeyrou B
De Pauw-Gillet MC
Colson P
Houssier C
Cimanga K
Van Miert S
Vlietinck AJ
Pieters L
Source :
Anti-cancer drug design [Anticancer Drug Des] 2000 Jun; Vol. 15 (3), pp. 191-201.
Publication Year :
2000

Abstract

Cryptolepine and neocryptolepine are two indoloquinoline alkaloids isolated from the roots of the African plant Cryptolepis sanguinolenta. Both drugs have revealed antibacterial and antiparasitic activities and are strongly cytotoxic to tumour cells. We have recently shown that cryptolepine can intercalate into DNA and stimulates DNA cleavage by human topoisomerase II. In this study, we have investigated the mechanism of action and cytotoxicity of neocryptolepine, which differs from the parent isomer only by the orientation of the indole unit with respect to the quinoline moiety. The biochemical and physicochemical results presented here indicate that neocryptolepine also intercalates into DNA, preferentially at GC-rich sequences, but exhibits a reduced affinity for DNA compared with cryptolepine. The two alkaloids interfere with the catalytic activity of human topoisomerase II but the poisoning activity is slightly more pronounced with cryptolepine than with its isomer. The data provide a molecular basis to account for the reduced cytotoxicity of neocryptolepine compared with the parent drug.

Details

Language :
English
ISSN :
0266-9536
Volume :
15
Issue :
3
Database :
MEDLINE
Journal :
Anti-cancer drug design
Publication Type :
Academic Journal
Accession number :
11049087